NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Asahi Kasei Therapeutics Venture Capital

Asahi Kasei Therapeutics Venture Capital

Tokyoasahi-kasei.com

Overview

Asahi Kasei Therapeutics Venture Capital is an evergreen strategic venture fund that invests internationally in private, early-stage biopharmaceutical and biotech companies, focusing on innovative therapeutics and platforms.

Year Founded

2018

Portfolio Companies

2

Investments

Asahi Kasei Therapeutics Venture Capital investments
CompanyDateStageLead
AzafarosMay 2025Series BCo-investor
GlycomineJun 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.